live attenuated vaccines market Statistics, Size, Share, Outlook and Dynamics Till 2027Posted by dgid shrikant on October 11th, 2022 Global Live Attenuated Vaccines Market – Overview A variety of vaccines are available in the market to train the immune system how to fight off certain kinds of germs and the serious diseases they cause. The developmental procedure of vaccines depends upon various factors including immune system responds to the antigen, type of vaccination needed, cost of manufacturing. Thus, based on methodology and technique, vaccine is classified into live-attenuated vaccines, inactivated vaccines subunit, recombinant, polysaccharide, and conjugate vaccines, and toxoid vaccines. Live vaccines when have weakened (attenuated) form of the antigen, then it is referred to as attenuated vaccine. The advantage associated with such vaccines is inclusive of natural infection mechanism leading to strong and long-lasting immune response. Factors such as increasing awareness about vaccination, growing government funding for vaccination programs and increasing prevalence of infectious diseases drive the growth of this market. The developing economies of the Asia Pacific like India has the largest number of births in the world, i.e., more than 26 million per year. According to the United Nations Children's Emergency Fund, ~ 20% of the total child mortality across the globe are reported in India. Thus, the Indian government is aiming to provide immunization to the children, to improve health and raise life expectancy of the infants. For instance, it is reported that nine million routine immunization (RI) sessions are organized in India each year. Moreover, economies like China within the region are witnessing an increase in the investment support for vaccination. Gavi is estimated to invest USD 800,000 from 2001-2022 in the form of Vaccine Introduction Grant (VIG) for China. Moreover, improving healthcare infrastructure, increasing demand for LAV, and emphasis on prevention of diseases also drives this market. However, factors such as limited efficiency and high cost of development are the majors factors estimated to restraint the market growth during the forecast period. Global live attenuated vaccines market is projected to reach USD 45.2 billion by 2023 from USD 34.2 billion in 2016 with an approximate CAGR of 10.7% from 2022 to 2027. Top Players List: GlaxoSmithKline, plc. (U.K.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Astellas Pharma Inc. (Japan), Johnson & Johnson (U.S.), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), MedImmune, LLC (U.S.), Sanofi (France), and Serum Institute of India Pvt. Ltd. (India). and others are some of the prominent players at the forefront of competition in the Global Live Attenuated Vaccines Market and are profiled in MRFR Analysis. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1101 Global Live Attenuated Vaccines Market - Competitive Analysis Companies in the global market for live attenuated vaccines are continuously increasing their research and development expenses in order to development new products and technologies, which could maximize their share of global market. In September, 2016- Glaxo SmithKline Pharmaceuticals (GSK Pharma) completed the announced acquisition of Novartis’s vaccine business and sale of its oncology business. Following the course of deal GSK was able to expand their vaccine portfolio and has absorbed approximately mor120 employees from Novartis to ramp up its sales in India. In June, 2018- announced that the U.S. Food and Drug Administration (FDA) recognised their review for new supplemental Biologics License Application (sBLA) for GARDASIL which is a human papillomavirus vaccine. Global Live Attenuated Vaccines Market - Regional Analysis The Americas leads the live attenuated vaccine market. Factors such as increasing healthcare infrastructure and increasing government support are the major drivers for the market within the region. Followed by the Americas, Europe holds the second largest market, owing to the huge presence of prominent players and well-developed healthcare infrastructure. Moreover, the presence of development economies like the Germany, France, Italy, and others along with research and development provides suitable backgrounds for the market to grow. Asia Pacific is the fastest growing market due to the presence of countries like India, China, and others. Such developing economies have high potential of generating business for market players. Followed by the Asia Pacific region, the Middle East & Africa holds the lowest share of the market. Most of the countries within this region are low income countries with low per capita healthcare expenditure, and stringent government policies. In the Middle East & African region. The Middle Eastern region in the Middle East & Africa is estimated to lead the market due the presence of developed economies like Saudi Arabia, Kuwait, Dubai, Qatar, and others within the regional boundaries. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/live-attenuated-vaccines-market-1101 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 628 258 0071 Email: sales@marketresearchfuture.com Like it? Share it! More by this author |